Search results for "Chloride"

showing 10 items of 1691 documents

Assessment of DNA-protein crosslinks in the course of aging in two mouse strains by use of a modified alkaline filter elution applied to whole tissue…

1999

Abstract Two different mouse strains have been used for determination of age dependence of DNA-protein crosslinks by alkaline filter elution: a long lived laboratory strain, NMRI and an accelerated senescence-prone, short lived strain, SAMP1. Five organs were selected: Brain, kidney, lung, heart and liver. Remarkably in all five organs of short lived SAMP1 mice crosslinks increased significantly with age. In NMRI however only in brain and heart a significant rise in old age has been observed, while in the other organs there was no increase in DNA-protein crosslinking. Appreciable mitotic activity which is lacking in brain and heart could be the reason for this difference. Poor repair in all…

Agingmedicine.medical_specialtyProtein dnaSodium ChlorideBiologyMiceInternal medicinemedicineAnimalsHumansMitosisKidneyLungStrain (chemistry)Life spanElutionProteinsDNACross-Linking Reagentsmedicine.anatomical_structureEndocrinologyBiochemistryFemaleEndopeptidase KHeLa CellsDevelopmental BiologyMechanisms of Ageing and Development
researchProduct

Inhibition of human detrusor contraction by a urothelium derived factor.

2003

Stimulating muscarinic receptors in pig bladder urothelium causes the release of a diffusable factor that inhibits contractions of the underlying detrusor muscle. We investigated whether the contractions of human detrusor strips elicited by the muscarinic agonist carbachol, electrical field stimulation, KCl or the neurokinin receptor agonist neurokinin A are affected by the urothelium.Paired intact and urothelium denuded muscle strips were placed in modified gassed Tyrode's solution at 37C. Cumulative concentration-response curves to carbachol or KCl were constructed. In other tissues the strips were stimulated electrically (1 to 40 Hz) with trains of square wave pulses 20 seconds in durati…

AgonistDetrusor muscleMalemedicine.medical_specialtyCarbacholmedicine.drug_classUrologyNeurokinin APig bladderMuscarinic Agonistsurologic and male genital diseasesMuscarinic agonistPotassium Chloridechemistry.chemical_compoundInternal medicineCulture TechniquesMuscle HypertoniamedicineHumansUrotheliumAgedDose-Response Relationship Drugurogenital systembusiness.industryTissue ExtractsMuscle SmoothMiddle Agedfemale genital diseases and pregnancy complicationsElectric StimulationStimulation ChemicalEndocrinologymedicine.anatomical_structurechemistryCarbacholFemaleNeurokinin Amedicine.symptomUrotheliumbusinessmedicine.drugMuscle contractionMuscle ContractionThe Journal of urology
researchProduct

Effect of divalent cations on KCl- and noradrenaline-induced contractile responses in rat aorta after nifedipine treatment.

1999

Abstract Nifedipine (1 μM) relaxed the sustained contractile responses induced by 1 μM noradrenaline or 60 mM KCl in rat aortic strips. After washing, a second addition of the spasmogens gave smaller tonic contractions than the first one. Even more, a third addition of KCl also gave a smaller contraction than the first one, but a complete recovery of the contractile response to noradrenaline was obtained by a third addition of this agonist. Application of cumulative amounts of Ca2+ or Ba2+ (2.4–24 mM) on the residual contraction in response to these agents after nifedipine treatment, but in the absence of the blocker, restored the magnitude of the contractile responses. Addition of cumulati…

AgonistMalemedicine.medical_specialtyContraction (grammar)Nifedipinemedicine.drug_classCations DivalentVasodilator AgentsAorta ThoracicIn Vitro TechniquesTonic (physiology)DivalentPotassium ChlorideNorepinephrineNifedipineInternal medicinemedicine.arterymedicineAnimalsVasoconstrictor AgentsRats WistarPharmacologychemistry.chemical_classificationAortaChemistryCardiovascular AgentsRatsEndocrinologyVasoconstrictionCalciummedicine.symptomIsotonic SolutionsVasoconstrictionMuscle contractionmedicine.drugGeneral pharmacology
researchProduct

DIFFERENT ABILITY OF TRIFLUOPERAZINE TO INHIBIT AGONIST-INDUCED CONTRACTION OF LUNG PARENCHYMA STRIPS FROM CONTROL AND SENSITIZED GUINEA-PIGS

1988

Abstract There is increasing interest in the therapeutic potential of calcium antagonists in asthma. Among them the use of calmodulin antagonists deserves consideration. In the present work the effect of trifluoperazine on contractions generated by different mechanisms (CaCl2, KCl, acetylcholine, histamine and 5-hydroxytryptamine) in lung parenchyma strip isolated from control and actively sensitized guinea-pigs has been studied. Trifluoperazine produced both in unsensitized and sensitized lung strips, a concentration-dependent, right, downward displacement of the concentration-response curves to the agonists used, although the sensitization procedure resulted in a potentiation in the abili…

AgonistMalemedicine.medical_specialtySerotoninmedicine.drug_classGuinea PigsPharmaceutical ScienceTrifluoperazineIn Vitro TechniquesPotassium ChlorideContractilityGuinea pigchemistry.chemical_compoundCalcium ChlorideInternal medicineParenchymamedicineAnimalsLungSensitizationPharmacologyMuscle SmoothAcetylcholineTrifluoperazinemedicine.anatomical_structureEndocrinologychemistryHistamineAcetylcholinemedicine.drugHistamineMuscle Contraction
researchProduct

Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes.

1993

To analyse the potency of glycopyrronium bromide in blocking responses mediated via subtypes of muscarinic receptors in vitro, we tried to determine its equilibrium dissociation constants at prejunctional muscarinic receptors inhibiting the twitch response of rabbit vas deferens (presumed M1 type), at M2 (paced at left atria), M3 (guinea pig ileum) muscarinic receptor subtypes and at the muscarinic receptor of the rabbit iris sphincter (not M1-M4, not m5). Glycopyrronium bromide shifted to the right the curve for inhibition of the twitch response induced by the agonist McN-A-343, and the methacholine-induced curves for inhibition of rat atrial contraction, and for tonic contraction of guine…

AgonistMalemedicine.medical_specialtymedicine.drug_classGuinea PigsIrisMuscarinic AntagonistsIn Vitro TechniquesModels BiologicalVas DeferensInternal medicineMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor M4medicineAnimalsMethacholine CompoundsGlycopyrronium bromidePharmacologyChemistryVas deferens(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium ChlorideMuscarinic acetylcholine receptor M3ParasympatholyticsMuscarinic acetylcholine receptor M2HeartMuscle SmoothGeneral MedicineMuscarinic acetylcholine receptor M1GlycopyrrolateRatsEndocrinologymedicine.anatomical_structureFemaleRabbitsmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

2020

Abstract Fingolimod is an approved treatment for relapsing–remitting multiple sclerosis (MS), and its properties in different pathways have raised interest in therapy research for other neurodegenerative diseases. Fingolimod is an agonist of sphingosine-1-phosphate (S1P) receptors. Its main pharmacologic effect is immunomodulation by lymphocyte homing, thereby reducing the numbers of T and B cells in circulation. Because of the ubiquitous expression of S1P receptors, other effects have also been described. Here, we review preclinical experiments evaluating the effects of treatment with fingolimod in neurodegenerative diseases other than MS, such as Alzheimer’s disease or epilepsy. Fingolimo…

AgonistSphingosine 1 Phosphate Receptor ModulatorsMultiple Sclerosismedicine.drug_classDrug Evaluation PreclinicalDiseaseReview ArticleRM1-950PharmacologyNeuroprotection03 medical and health sciencesEpilepsyMice0302 clinical medicineNeurotrophic factorsAlzheimer DiseasemedicineAnimalsHumansLymphocytes030304 developmental biologyPharmacology0303 health sciencesEpilepsyMicrogliabusiness.industryFingolimod HydrochlorideMultiple sclerosisAnti-Inflammatory Agents Non-Steroidalmedicine.diseaseFingolimod3. Good healthRatsDisease Models Animalmedicine.anatomical_structureNeuroprotective AgentsTherapeutics. PharmacologyNervous System Diseasesbusiness030217 neurology & neurosurgerymedicine.drugDrugs in R&D
researchProduct

Influence of hormonal treatment on the response of the rat isolated uterus to histamine and histamine receptor agonists.

1992

The response of the isolated uterus to histamine and histamine agonists was investigated in progesterone- and oestrogen-treated rats. The uterine inhibitory responses to histamine and 4-methylhistamine (a histamine H2 receptor agonist) were similar in KCl-contracted uteri from progesterone- and oestrogen-treated rats. The histamine H1 receptor agonist, 2-pyridyl-ethylamine, produced a relaxant response only in progesterone dominant uterus. This was inhibited by the histamine H1 receptor antagonist. In the rat isolated uterus which was not preconstricted by KCl, neither histamine, 4-methylhistamine, nor 2-pyridyl-ethylamine produced any effect in the presence or absence of ranitidine. Raniti…

Agonistmedicine.medical_specialtymedicine.drug_classPyridinesHistamine H1 receptorBiologyRanitidineHistamine agonistPotassium ChlorideRanitidinechemistry.chemical_compoundHistamine receptorUterine ContractionHistamine H2 receptorInternal medicinemedicineAnimalsDrug InteractionsHistamine H4 receptorProgesteronePharmacologyMethylhistaminesUterusEstrogensRats Inbred StrainsRatsEndocrinologychemistryReceptors HistamineFemaleHistaminemedicine.drugHistamineEuropean journal of pharmacology
researchProduct

Sequential Therapy with Azelastine in Seasonal Allergic Rhinitis

2011

A sequential therapy treatment with azelastine (Allergodil (r) ) in seasonal allergic rhinitis is introduced. In the critical early stage, treatment begins with a combination of azelastine tablets (azelastine hydrochloride, CAS 79307-93-0) and azelastine nasal spray (azelastine, CAS 58581-89-8), and after five days only the nasal spray is administered. This sequential therapy model aims at achieving the quickest and most complete effect without reducing the tolerability. The investigation was carried out as a randomized, controlled double-blind phase IV study of parallel group design with 300 patients during 14 days. In the first five days, one group was given one puff (0.14 mg) of azelasti…

AllergyAzelastine HydrochlorideCombination therapybusiness.industrymedicine.medical_treatmentPlacebomedicine.diseaseAzelastineTolerabilityNasal sprayOral administrationAnesthesiaDrug Discoverymedicinebusinessmedicine.drugArzneimittelforschung
researchProduct

Airways Hyperresponsiveness and the Effects of Lung Inflation

2001

Lung inflation has a beneficial effect on the airways of healthy subjects. It acts as a bronchoprotector, that is to prevent bronchoconstriction, and as a bronchodilator, in that it reverses bronchial obstruction. The bronchoprotective effect of deep inspiration is more potent than the bronchodilatory one, and the two phenomena appear to advocte different mechanisms. Asthmatics and rhinitics with airways hyperresponsiveness show an impairment in bronchoprotection induced by deep breaths, whereas the bronchodilatory effect, although reduced, is still effective. The lack of the bronchoprotective effect of deep inspiration may contribute to the development of airways hyperresponsiveness. The m…

Allergymedicine.drug_classImmunologyProvocation testSettore MED/10 - Malattie Dell'Apparato RespiratorioNitric OxideModels BiologicalBronchial Provocation TestsBronchoconstrictor AgentsForced Expiratory VolumeBronchodilatormedicineHumansImmunology and AllergyMethacholine ChlorideAsthmabusiness.industryRespiratory diseaseGeneral Medicinerespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesBronchial Provocation Testmedicine.anatomical_structureBronchoconstrictor AgentImmunologyBronchoconstrictionMethacholineBronchial Hyperreactivitymedicine.symptomPulmonary VentilationbusinessHumanRespiratory tractmedicine.drugInternational Archives of Allergy and Immunology
researchProduct

Efficient Addition of Acid Enediolates to Epoxides

2004

We report new conditions to facilitate the addition of dianions of carboxylic acids to epoxides as an alternative method to the use of aluminum enolates. These conditions require the use of a sub-stoichiometric (10%) amount of amine for dianion generation and the previous activation of the epoxide with LiCl. Other Lewis acids have been shown to be less effective. Yields are good but only low diastereoselectivity is attained, which has not been controlled despite attempts at optimization. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)

Alternative methodschemistry.chemical_compoundNucleophilic additionchemistryOrganic ChemistryEpoxideLithium chlorideRegioselectivityOrganic chemistryAmine gas treatingLewis acids and basesPhysical and Theoretical ChemistryEuropean Journal of Organic Chemistry
researchProduct